Eli Lilly’s (LLY) latest vaccine shopping spree and GeoVax Labs’s (GOVX) sharpened strategic focus together seemingly sketch a quietly bullish subplot in an otherwise noisy biotech market, giving investors a fresh angle on infectious disease and immuno-oncology risk-on exposure.
Big Pharma…
